Senate Passes User Fee Package With Ease
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanders casts the lone dissenting vote, saying it does not do enough to curb drug costs. Pay-for-delay and drug reimportation amendments fail.
You may also be interested in...
US FDA Aims To Speed Communications On Cell And Gene Therapy Issues With Q&A Guidance
Advocates also call for reauthorization negotiations to be open to the public during meeting on the PDUFA VII commitment letter.
Califf Nomination Hearing Expected Before Holiday Season
The Senate HELP Committee has competing priorities, but the FDA commissioner nominee still seems to have smooth path to confirmation.
Califf Nomination Hearing Expected Before Holiday Season
The Senate HELP Committee has competing priorities, but the FDA commissioner nominee still seems to have smooth path to confirmation.